1. 方法論と範囲
1.1. 調査方法
1.2. 調査目的と調査範囲
2. 定義と概要
3. エグゼクティブ・サマリー
3.1. 薬剤タイプ別スニペット
3.2. 用途別スニペット
3.3. 投与経路別スニペット
3.4. エンドユーザー別スニペット
3.5. 地域別スニペット
4. ダイナミクス
4.1. 影響要因
4.1.1. 推進要因
4.1.1.1. 食肉および動物性製品の需要増加
4.1.1.2. 動物における細菌感染の流行
4.1.2. 阻害要因
4.1.2.1. タイロシンに伴う合併症
4.1.2.2. XX
4.1.3. 機会
4.1.4. 影響分析
5. 産業分析
5.1. ポーターのファイブフォース分析
5.2. サプライチェーン分析
5.3. 価格分析
5.4. 規制分析
5.5. 特許分析
5.6. PESTLE分析
5.7. SWOT分析
5.8. DMI意見
6. 医薬品タイプ別
6.1. はじめに
6.1.1. 薬物タイプ別市場規模分析および前年比成長率分析（%） 6.1.2.
6.1.2. 市場魅力度指数（薬物タイプ別
6.2. 酒石酸タイロシン
6.2.1. 序論
6.3. リン酸タイロシン
6.4. チロシン塩基
6.5. その他
7. 用途別
7.1. 導入
7.1.1. 市場規模分析および前年比成長率分析（%）, アプリケーション別
7.2. 市場魅力度指数、用途別
7.3. 動物*市場
7.3.1. はじめに
7.3.2. 市場規模分析と前年比成長率分析(%)
7.4. イヌ
7.5. 家畜
7.6. その他
8. 投与経路別
8.1. はじめに
8.1.1. 市場規模分析および前年比成長率分析（%）、投与経路別
8.1.2. 市場魅力度指数、用途別
8.2. 経口*剤
8.2.1. 序論
8.2.2. 市場規模分析と前年比成長率分析(%)
8.3. 注射剤
9. エンドユーザー別
9.1. 導入剤
9.1.1. 市場規模分析および前年比成長率分析(%), エンドユーザー別
9.1.2. 市場魅力度指数、エンドユーザー別
9.2. 動物病院
9.2.1. はじめに
9.2.2. 市場規模分析と前年比成長率分析(%)
9.3. 畜産農場
9.4. 動物飼料メーカー
9.5. 製薬会社
10. 地域別
10.1. はじめに
10.1.1. 地域別市場規模分析および前年比成長率分析(%)
10.1.2. 市場魅力度指数、地域別
10.2. 北米
10.2.1. 序論
10.2.2. 主な地域別ダイナミクス
10.2.3. 薬剤タイプ別市場規模分析および前年比成長率分析（%） 10.2.4.
10.2.4. 市場規模分析およびYoY成長率分析（%）、用途別
10.2.5. 市場規模分析および前年比成長率分析（%）, 投与経路別
10.2.6. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
10.2.7. 市場規模分析および前年比成長率分析（%）, 国別
10.2.7.1. 米国
10.2.7.2. カナダ
10.2.7.3. メキシコ
10.3. ヨーロッパ
10.3.1. はじめに
10.3.2. 主な地域別ダイナミクス
10.3.3. 薬剤タイプ別市場規模分析および前年比成長率分析（%） 10.3.4.
10.3.4. 市場規模分析およびYoY成長率分析（%）、用途別
10.3.5. 市場規模分析および前年比成長率分析（%）, 投与経路別
10.3.6. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
10.3.7. 市場規模分析および前年比成長率分析（%）, 国別
10.3.7.1. ドイツ
10.3.7.2. イギリス
10.3.7.3. フランス
10.3.7.4. イタリア
10.3.7.5. スペイン
10.3.7.6. その他のヨーロッパ
10.4. 南米
10.4.1. はじめに
10.4.2. 地域別主要市場
10.4.3. 薬剤タイプ別市場規模分析および前年比成長率分析（%） 10.4.4.
10.4.4. 市場規模分析およびYoY成長率分析（%）、用途別
10.4.5. 市場規模分析および前年比成長率分析（%）, 投与経路別
10.4.6. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
10.4.7. 市場規模分析および前年比成長率分析（%）, 国別
10.4.7.1. ブラジル
10.4.7.2. アルゼンチン
10.4.7.3. その他の南米諸国
10.5. アジア太平洋
10.5.1. 序論
10.5.2. 主な地域別ダイナミクス
10.5.3. 薬剤タイプ別市場規模分析および前年比成長率分析（%） 10.5.4.
10.5.4. 市場規模分析およびYoY成長率分析（%）、用途別
10.5.5. 市場規模分析および前年比成長率分析（%）, 投与経路別
10.5.6. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
10.5.7. 市場規模分析および前年比成長率分析（%）, 国別
10.5.7.1. 中国
10.5.7.2. インド
10.5.7.3. 日本
10.5.7.4. 韓国
10.5.7.5. その他のアジア太平洋地域
10.6. 中東・アフリカ
10.6.1. 序論
10.6.2. 主な地域別ダイナミクス
10.6.3. 薬剤タイプ別市場規模分析および前年比成長率分析（%） 10.6.4.
10.6.4. 市場規模分析およびYoY成長率分析（%）、用途別
10.6.5. 市場規模分析および前年比成長率分析（%）, 投与経路別
10.6.6. 市場規模分析および前年比成長率分析（%）：エンドユーザー別
11. 競合情勢
11.1. 競争シナリオ
11.2. 市場ポジショニング／シェア分析
11.3. M&A分析
12. 企業プロフィール
12.1. Zoetis*
12.1.1. 会社概要
12.1.2. 製品ポートフォリオと内容
12.1.3. 財務概要
12.1.4. 主な展開
12.2. Tairui Pharmaceuticals
12.3. Lukang Pharmaceutical
12.4. Henan Hualun
12.5. Qilu Pharmaceutical (Inner Mongolia) Co., Ltd
12.6. Huvepharma
12.7. AdvaCare Pharma
12.8. Elanco Animal Health
12.9. Apeloa Kangyu
12.10. Top Pharm Chemical Group
リストは網羅的ではありません
13. 付録
13.1. 会社概要とサービス
13.2. お問い合わせ

Overview
Global Tylosin Market reached US$ 440 million in 2023 and is expected to reach US$ 605 million by 2031, growing at a CAGR of 3.9% during the forecast period 2024-2031.

Tylosin is a macrolide antibiotic used in veterinary medicine to treat bacterial infections in livestock, including cattle, pigs, and poultry. It is effective against gram-positive and some gram-negative bacteria and mycoplasma species. Tylosin is used for respiratory, mastitis, and digestive system infections, and is valued for its anti-inflammatory properties and growth promotion. However, its use in food-producing animals is regulated to prevent antibiotic resistance.

Market Dynamics: Drivers & Restraints
Rise in demand for meat and animal based products
One key driver of the global tylosin market is the rising demand for meat and animal-based products, particularly in emerging economies. As global populations grow and incomes rise, especially in countries like China and India, there is an increasing demand for protein-rich diets, which in turn boosts the livestock industry. To maintain the health and productivity of livestock, Tylosin is commonly used to treat bacterial infections and promote animal growth. This heightened need for efficient livestock management and disease control to meet the rising demand for meat has significantly contributed to the growth of the Tylosin market.

Complications associated with tylosin
The side effects associated with the use of tylosin, such as diarrhea, vomiting, and gastrointestinal disturbances, are another factor limiting the market growth. The increasing awareness about the potential health risks associated with the use of antibiotics in animals is also expected to hamper the market growth.

Segment Analysis
The global tylosin market is segmented based on drug type, application, route of administration, end user and region.
The tylosin tartrate from the drug type segment accounted for approximately 41.3% of the tylosin market share
The tylosin tartrate from the drug type segment accounted for approximately 41.3%. Tylosin Tartrate is a widely used antibiotic due to its water-soluble properties, making it convenient for treating large groups of animals like poultry, swine, and cattle. It is effective in combating respiratory infections, mycoplasma, and gastrointestinal diseases. Its ease of administration and rapid absorption in animals make it a popular choice in the veterinary industry. As livestock farming expands globally, particularly in regions focused on mass animal production, the demand for Tylosin Tartrate remains strong.

Geographical Analysis
North America is estimated to hold about 41.04% of the total market share throughout the forecast period
North America is estimated to hold about 41.04% of the total market share throughout the forecast period due to presence of leading pharmaceutical companies focusing on animal health. Additionally, stringent regulations governing antibiotic usage in animal husbandry contribute to the adoption of tylosin-based products in this region.
Moreover, North American Tylosin market is a significant global segment, driven by the US and Canada's established livestock and poultry industries. The high demand for meat and dairy products has led to increased livestock farming, requiring effective veterinary antibiotics like Tylosin. Tylosin is widely used to prevent and treat bacterial infections in animals and improve growth rates, but its use is increasingly regulated due to concerns over antibiotic resistance.

Market Segmentation
By Drug Type
• Tylosin Tartrate
• Tylosin Phosphate
• Tylosin Base
• Others
By Application
• Felines
• Canines
• Livestock
• Others
By Route of Administration
• Oral
• Injectable
By End-User
• Veterinary Clinics
• Livestock Farms
• Animal Feed Manufacturers
• Pharmaceutical Companies
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape
The major global players in the market include Zoetis, Tairui Pharmaceuticals, Lukang Pharmaceutical, Henan Hualun, Qilu Pharmaceutical (Inner Mongolia) Co., Ltd, Huvepharma, AdvaCare Pharma, Elanco Animal Health, Apeloa Kangyu, Top Pharm Chemical Group among others.

Why Purchase the Report?
• To visualize the global tylosin
Market Segmentation based on drug type, application, route of administration, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of the tylosin market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global tylosin market report would provide approximately 64 tables, 61 figures and 186 pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Drug Type
3.2. Snippet by Application
3.3. Snippet by Route of Administration
3.4. Snippet by End User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rise in demand for meat and animal-based products
4.1.1.2. Prevalence of bacterial infections in animals
4.1.2. Restraints
4.1.2.1. Complications associated with tylosin
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Patent Analysis
5.6. PESTLE Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. By Drug Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Type
6.1.2. Market Attractiveness Index, By Drug Type
6.2. Tylosin Tartrate*
6.2.1. Introduction
6.3. Tylosin Phosphate
6.4. Tylosin Base
6.5. Others
7. By Application
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.2. Market Attractiveness Index, By Application
7.3. Felines*
7.3.1. Introduction
7.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.4. Canines
7.5. Livestock
7.6. Others
8. By Route of Administration
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
8.1.2. Market Attractiveness Index, By Application
8.2. Oral*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Injectable
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Veterinary Clinics*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Livestock Farms
9.4. Animal Feed Manufacturers
9.5. Pharmaceutical Companies
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.7.1. U.S.
10.2.7.2. Canada
10.2.7.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.7.1. Germany
10.3.7.2. UK
10.3.7.3. France
10.3.7.4. Italy
10.3.7.5. Spain
10.3.7.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.7.1. Brazil
10.4.7.2. Argentina
10.4.7.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. China
10.5.7.2. India
10.5.7.3. Japan
10.5.7.4. South Korea
10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Zoetis*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Tairui Pharmaceuticals
12.3. Lukang Pharmaceutical
12.4. Henan Hualun
12.5. Qilu Pharmaceutical (Inner Mongolia) Co., Ltd
12.6. Huvepharma
12.7. AdvaCare Pharma
12.8. Elanco Animal Health
12.9. Apeloa Kangyu
12.10. Top Pharm Chemical Group
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

*** タイロシンの世界市場に関するよくある質問(FAQ) ***

・タイロシンの世界市場規模は？
→DataM Intelligence社は2023年のタイロシンの世界市場規模を4億4,000万米ドルと推定しています。

・タイロシンの世界市場予測は？
→DataM Intelligence社は2031年のタイロシンの世界市場規模を6億500万米ドルと予測しています。

・タイロシン市場の成長率は？
→DataM Intelligence社はタイロシンの世界市場が2024年～2031年に年平均3.9%成長すると展望しています。

・世界のタイロシン市場における主要プレイヤーは？
→「Zoetis、Tairui Pharmaceuticals、Lukang Pharmaceutical、Henan Hualun、Qilu Pharmaceutical (Inner Mongolia) Co., Ltd、Huvepharma、AdvaCare Pharma、Elanco Animal Health、Apeloa Kangyu、Top Pharm Chemical Groupなど ...」をタイロシン市場のグローバル主要プレイヤーとして判断しています。

※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、最終レポートの情報と少し異なる場合があります。

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/